πŸ‡ΊπŸ‡Έ FDA
Patent

US 10456448

PTD-SMAD7 therapeutics

granted A61KA61K38/00A61K38/162

Quick answer

US patent 10456448 (PTD-SMAD7 therapeutics) held by The Regents of the University of Colorado, a Body Corporate expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K38/00, A61K38/162, A61K38/18, A61K48/005